These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 30848041)

  • 21. Prediction of Axillary Lymph Node Metastasis in Early-stage Triple-Negative Breast Cancer Using Multiparametric and Radiomic Features of Breast MRI.
    Song SE; Woo OH; Cho Y; Cho KR; Park KH; Kim JW
    Acad Radiol; 2023 Sep; 30 Suppl 2():S25-S37. PubMed ID: 37331865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of Lymphovascular Invasion in Breast Cancer Using a Combined MRI Morphological Features, Radiomics, and Deep Learning Approach Based on Dynamic Contrast-Enhanced MRI.
    Yang X; Fan X; Lin S; Zhou Y; Liu H; Wang X; Zuo Z; Zeng Y
    J Magn Reson Imaging; 2024 Jun; 59(6):2238-2249. PubMed ID: 37855421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive value of MRI-based deep learning model for lymphovascular invasion status in node-negative invasive breast cancer.
    Liang R; Li F; Yao J; Tong F; Hua M; Liu J; Shi C; Sui L; Lu H
    Sci Rep; 2024 Jul; 14(1):16204. PubMed ID: 39003325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiomic Signature Based on Dynamic Contrast-Enhanced MRI for Evaluation of Axillary Lymph Node Metastasis in Breast Cancer.
    Tang Y; Chen L; Qiao Y; Li W; Deng R; Liang M
    Comput Math Methods Med; 2022; 2022():1507125. PubMed ID: 36035302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of Axillary Lymph Node Metastasis in Breast Cancer using Intra-peritumoral Textural Transition Analysis based on Dynamic Contrast-enhanced Magnetic Resonance Imaging.
    Zhan C; Hu Y; Wang X; Liu H; Xia L; Ai T
    Acad Radiol; 2022 Jan; 29 Suppl 1():S107-S115. PubMed ID: 33712393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiparametric MRI model with dynamic contrast-enhanced and diffusion-weighted imaging enables breast cancer diagnosis with high accuracy.
    Zhang M; Horvat JV; Bernard-Davila B; Marino MA; Leithner D; Ochoa-Albiztegui RE; Helbich TH; Morris EA; Thakur S; Pinker K
    J Magn Reson Imaging; 2019 Mar; 49(3):864-874. PubMed ID: 30375702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiomics model of diffusion-weighted whole-body imaging with background signal suppression (DWIBS) for predicting axillary lymph node status in breast cancer.
    Haraguchi T; Kobayashi Y; Hirahara D; Kobayashi T; Takaya E; Nagai MT; Tomita H; Okamoto J; Kanemaki Y; Tsugawa K
    J Xray Sci Technol; 2023; 31(3):627-640. PubMed ID: 37038802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breast imaging. Preoperative breast cancer staging: comparison of USPIO-enhanced MR imaging and 18F-fluorodeoxyglucose (FDC) positron emission tomography (PET) imaging for axillary lymph node staging--initial findings.
    Stadnik TW; Everaert H; Makkat S; Sacré R; Lamote J; Bourgain C
    Eur Radiol; 2006 Oct; 16(10):2153-60. PubMed ID: 16670863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-invasive prediction of axillary lymph node dissection exemption in breast cancer patients post-neoadjuvant therapy: A radiomics and deep learning analysis on longitudinal DCE-MRI data.
    Yu Y; Chen R; Yi J; Huang K; Yu X; Zhang J; Song C
    Breast; 2024 Oct; 77():103786. PubMed ID: 39137488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) mapping as a quantitative imaging biomarker for prediction of immunohistochemical receptor status, proliferation rate, and molecular subtypes of breast cancer.
    Horvat JV; Bernard-Davila B; Helbich TH; Zhang M; Morris EA; Thakur SB; Ochoa-Albiztegui RE; Leithner D; Marino MA; Baltzer PA; Clauser P; Kapetas P; Bago-Horvath Z; Pinker K
    J Magn Reson Imaging; 2019 Sep; 50(3):836-846. PubMed ID: 30811717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multitask Deep Learning-Based Whole-Process System for Automatic Diagnosis of Breast Lesions and Axillary Lymph Node Metastasis Discrimination from Dynamic Contrast-Enhanced-MRI: A Multicenter Study.
    Zhou H; Hua Z; Gao J; Lin F; Chen Y; Zhang S; Zheng T; Wang Z; Shao H; Li W; Liu F; Li Q; Chen J; Wang X; Zhao F; Qu N; Xie H; Ma H; Zhang H; Mao N
    J Magn Reson Imaging; 2024 May; 59(5):1710-1722. PubMed ID: 37497811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Difference of DCE-MRI Parameters at Different Time Points and Their Predictive Value for Axillary Lymph Node Metastasis of Breast Cancer.
    Ya G; Wen F; Xing-Ru L; Zhuan-Zhuan G; Jun-Qiang L
    Acad Radiol; 2022 Jan; 29 Suppl 1():S79-S86. PubMed ID: 33504446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiomic signature as a predictive factor for lymph node metastasis in early-stage cervical cancer.
    Kan Y; Dong D; Zhang Y; Jiang W; Zhao N; Han L; Fang M; Zang Y; Hu C; Tian J; Li C; Luo Y
    J Magn Reson Imaging; 2019 Jan; 49(1):304-310. PubMed ID: 30102438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic Performance of Fused Diffusion-Weighted Imaging Using T1-Weighted Imaging for Axillary Nodal Staging in Patients With Early Breast Cancer.
    Kim SH; Shin HJ; Shin KC; Chae EY; Choi WJ; Cha JH; Kim HH
    Clin Breast Cancer; 2017 Apr; 17(2):154-163. PubMed ID: 27843006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A two-center study of a combined nomogram based on mammography and MRI to predict ALN metastasis in breast cancer.
    Hua Y; Peng Q; Han J; Fei J; Sun A
    Magn Reson Imaging; 2024 Jul; 110():128-137. PubMed ID: 38631535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The MR radiomic signature can predict preoperative lymph node metastasis in patients with esophageal cancer.
    Qu J; Shen C; Qin J; Wang Z; Liu Z; Guo J; Zhang H; Gao P; Bei T; Wang Y; Liu H; Kamel IR; Tian J; Li H
    Eur Radiol; 2019 Feb; 29(2):906-914. PubMed ID: 30039220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of the number of metastatic axillary lymph nodes in breast cancer by radiomic signature based on dynamic contrast-enhanced MRI.
    Li L; Yu T; Sun J; Jiang S; Liu D; Wang X; Zhang J
    Acta Radiol; 2022 Aug; 63(8):1014-1022. PubMed ID: 34162234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of axillary lymph nodes in patients with breast cancer with diffusion-weighted MR imaging in combination with routine and dynamic contrast MR imaging.
    Razek AA; Lattif MA; Denewer A; Farouk O; Nada N
    Breast Cancer; 2016 May; 23(3):525-32. PubMed ID: 25763535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative Prediction of Axillary Lymph Node Metastasis in Breast Carcinoma Using Radiomics Features Based on the Fat-Suppressed T2 Sequence.
    Tan H; Gan F; Wu Y; Zhou J; Tian J; Lin Y; Wang M
    Acad Radiol; 2020 Sep; 27(9):1217-1225. PubMed ID: 31879160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic performance of standard breast MR imaging compared to dedicated axillary MR imaging in the evaluation of axillary lymph node.
    Ha SM; Chae EY; Cha JH; Shin HJ; Choi WJ; Kim HH
    BMC Med Imaging; 2020 May; 20(1):45. PubMed ID: 32357942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.